Chapter 3 Monoamine Transporter as a Target Molecule for Psychostimulants

International Review of Neurobiology

Volumn 85, Issue , 2009, Pages 29-33

  Sora, Ichiro ^a   Li, BingJin ^a   Fumushima, Setsu ^a   Fukui, Asami ^a   Arime, Yosefu ^a   Kasahara, Yoshiyuki ^a   Tomita, Hiroaki ^a   Ikeda, Kazutaka ^b  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE TRANSPORTER; METHAMPHETAMINE; MONOAMINE; PSYCHOSTIMULANT AGENT; SEROTONIN TRANSPORTER; VESICULAR MONOAMINE TRANSPORTER 2; CENTRAL STIMULANT AGENT; VESICULAR MONOAMINE TRANSPORTER;

AUDITORY HALLUCINATION; DELUSION; DRUG ABUSE; DRUG DEPENDENCE; GENE DELETION; HUMAN; HYPERTHERMIA; LOCOMOTION; MENTAL DISEASE; NERVE ENDING; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; PSYCHOSIS; REVIEW; SYNAPTIC TRANSMISSION; ANIMAL; ANIMAL BEHAVIOR; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FEVER; GENETICS; MOUSE; MOUSE MUTANT;

ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEVER; METHAMPHETAMINE; MICE; MICE, KNOCKOUT; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 67650066964     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(09)85003-4     Document Type: Review

References (18)

1. Broening H.W., Morford L.L., and Vorhees C.V. Interactions of dopamine D1 and D2 receptor antagonists with d-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions. Synapse 56 (2005) 84-93
2. Bronstein D.M., and Hong J.S. Effects of sulpiride and SCH 23390 on methamphetamine-induced changes in body temperature and lethality. J. Pharmacol. Exp. Ther. 274 (1995) 943-950
3. Davidson C., Gow A.J., Lee T.H., and Ellinwood E.H. Methamphetamine neurotoxicity: Necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res. Brain Res. Rev. 36 (2001) 1-22
4. Fukushima S., Shen H., Hata H., Ohara A., Ohmi K., Ikeda K., Numachi Y., Kobayashi H., Hall F.S., Uhl G.R., and Sora I. Methamphetamine-induced locomotor activity and sensitization in dopamine transporter and vesicular monoamine transporter 2 double mutant mice. Psychopharmacology (Berl.) 193 (2007) 55-62
5. Green A.R., Mechan A.O., Elliott J.M., O'Shea E., and Colado M.I. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol. Rev. 55 (2003) 463-508
6. Jones S.R., Gainetdinov R.R., Jaber M., Giros B., Wightman R.M., and Caron M.G. Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc. Natl. Acad. Sci. USA 95 (1998) 4029-4034
7. Kalivas P.W., Sorg B.A., and Hooks M.S. The pharmacology and neural circuitry of sensitization to psychostimulants. Behav. Pharmacol. 4 (1993) 315-334
8. Numachi Y., Ohara A., Yamashita M., Fukushima S., Kobayashi H., Hata H., Watanabe H., Hall F.S., Lesch K.P., Murphy D.L., Uhl G.R., and Sora I. Methamphetamine-induced hyperthermia and lethal toxicity: Role of the dopamine and serotonin transporters. Eur. J. Pharmacol. 572 (2007) 120-128
9. Robinson T.E., and Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis. Brain Res. 396 (1986) 157-198
10. Sato M., Chen C.C., Akiyama K., and Otsuki S. Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biol. Psychiatry 18 (1983) 429-440
11. Segal D.S., and Schuckit M.A. Animal models of stimulant-induced psychosis. In: Grees I. (Ed). Stimulants: Neurochemical, Behavioral and Clinical Perspectives (1983), Reven, New York 131-167
12. Seiden L.S., Sabol K.E., and Ricaurte G.A. Amphetamine: Effects on catecholamine systems and behavior. Annu. Rev. Pharmacol. Toxicol. 33 (1993) 639-677
13. Shen H.W., Hagino Y., Kobayashi H., Shinohara-Tanaka K., Ikeda K., Yamamoto H., Yamamoto T., Lesch K.P., Murphy D.L., Hall F.S., Uhl G.R., and Sora I. Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. Neuropsychopharmacology 29 (2004) 1790-1799
14. Sora I., Wichems C., Takahashi N., Li X.F., Zeng Z., Revay R., Lesch K.P., Murphy D.L., and Uhl G.R. Cocaine reward models: Conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. Proc. Natl. Acad. Sci. USA 95 (1998) 7699-7704
15. Sora I., Hall F.S., Andrews A.M., Itokawa M., Li X.F., Wei H.B., Wichems C., Lesch K.P., Murphy D.L., and Uhl G.R. Molecular mechanisms of cocaine reward: Combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc. Natl. Acad. Sci. USA 98 (2001) 5300-5305
16. Sulzer D., Sonders M.S., Poulsen N.W., and Galli A. Mechanisms of neurotransmitter release by amphetamines: A review. Prog. Neurobiol. 75 (2005) 406-433
17. Uhl G.R., Hall F.S., and Sora I. Cocaine, reward, movement and monoamine transporters. Mol. Psychiatry 7 (2002) 21-26
18. White F.J., and Kalivas P.W. Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend. 51 (1998) 141-153